Tucker John H — SEC Form 4 filings

SEC reporting owner CIK 1303480. 5 Form 4 filings on record with FilingPulse; latest filed 2025-10-07.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-22 to 2025-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
scPharmaceuticals Inc. (SCPH)President and CEO, Director512

Form 4 filings — Tucker John H

FiledFormIssuerReported transactionsSource
2025-10-074scPharmaceuticals Inc. (SCPH)Code (U): 122,345 · Disposition to issuer (D): 318,502 · Disposition to issuer (D): 300,000 (derivative) @ $0 · Disposition to issuer (D): 84,500 (derivative) @ $0 · Disposition to issuer (D): 249,000 (derivative) @ $0 · Disposition to issuer (D): 496,674 (derivative) @ $0EDGAR
2025-02-124scPharmaceuticals Inc. (SCPH)Grant/award (A): 200,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2025-01-074scPharmaceuticals Inc. (SCPH)Tax withholding (F): 13,360 @ $3.56EDGAR
2024-04-024scPharmaceuticals Inc. (SCPH)Grant/award (A): 56,025 (derivative) @ $0EDGAR
2024-01-224scPharmaceuticals Inc. (SCPH)Grant/award (A): 113,560 @ $0 · Grant/award (A): 170,340 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1303480 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →